3 completed, 3 terminated, 1 recruiting. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 3, Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Metastatic Prostatic Adenocarcinoma: new trials by email Literature Review of Metastatic Prostatic Adenocarcinoma trials Research Report on Metastatic Prostatic Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer 131I-PSMA-1095 Radioligand Therapy (RLT) - Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Terminated | Sir Mortimer B. Davis - Jewish General Hospital | 11 | 2020-07-31 | 2023-04-12 |
| A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma Opdivo Injectable Product, Yervoy Injectable Product, Cytoxan - Metastatic Prostatic Adenocarcinoma | Phase 2 | Completed | Rampart Health, L.L.C. | 12 | 2019-06-28 | 2022-06-21 |
| Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer Abiraterone Acetate, Antiandrogen Therapy, Docetaxel - Castration-Sensitive Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma | Phase 2 | Terminated | University of Utah | 1 | 2019-02-08 | 2020-06-25 |
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer Abiraterone, Bicalutamide, Degarelix - Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma | Phase 3 | Recruiting | SWOG Cancer Research Network | 1273 | 2018-09-24 | 2026-10-08 |
| Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer. Docetaxel, Degarelix - Metastatic Prostatic Adenocarcinoma | Phase 2 | Completed | Medical University of South Carolina | 52 | 2017-03-01 | 2025-10-15 |
| Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer Robotic Assisted Radical Prostatectomy, Conventional open retropubic radical prostectomy, Laboratory Biomarker Analysis - Metastatic Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma | Phase 1 | Completed | Rutgers, The State University of New Jersey | 26 | 2015-03-06 | 2021-04-08 |
| Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel Biopsy of Prostate, Docetaxel, Laboratory Biomarker Analysis - Hormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma | Phase 2 | Terminated | OHSU Knight Cancer Institute | 11 | 2010-07-12 | 2019-10-02 |
Genital Diseases (5) · Genital Diseases, Male (5) · Genital Neoplasms, Male (5) · Male Urogenital Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Prostatic Diseases (5) · Urogenital Diseases (5) · Urogenital Neoplasms (5)
Docetaxel (4) · Androgen Antagonists (2) · Prednisone (2) · acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (2) · deltacortene (2) · prednylidene (2) · Abiraterone Acetate (1) · Castration (1) · Cryosurgery (1) · Cyclophosphamide (1) · Flutamide (1) · Goserelin (1) · Ipilimumab (1) · Leuprolide (1) · Nivolumab (1)
Medical University of South Carolina (1) · OHSU Knight Cancer Institute (1) · Rampart Health, L.L.C. (1) · Rutgers, The State University of New Jersey (1) · SWOG Cancer Research Network (1) · Sir Mortimer B. Davis - Jewish General Hospital (1) · University of Utah (1)
United States (6) · Canada (1) · Chile (1) · Colombia (1) · Mexico (1) · Switzerland (1)
Benjamin Maughan, MD (1) · Brian Chapin (1) · David G Bostwick, M.D.,M.B.A. (1) · Isaac Kim (1) · Stephan Probst, MD (1) · Tomasz Beer (1)
P30CA069533 (1), P30CA072720 (1), U10CA180888 (1)